Lasa Supergenerics Ltd

Growth Ratio Summary

Growth Score : 5.20

The company's growth ratios show significant volatility. While operating profit and EPS growth rates are strong, revenue, asset, and net income growth rates are weak. This suggests that the company's profitability improvements may not be sustainable without broader growth across all areas. The healthcare industry's dynamic nature requires consistent growth in revenue and assets to maintain a competitive edge.

Financial Ratio Summary

Financial Score : 4.00

The financial ratios reveal a mixed performance. While capital expenditures are well-managed, adjusted EPS, book value per share, and dividend per share are low. Cash EPS is moderate. This suggests challenges in generating consistent earnings and shareholder value. The healthcare sector's regulatory and competitive pressures can affect these ratios, requiring strategic financial management.

Profitability Ratio Summary

Profitability Score : 2.20

The company's profitability ratios are generally weak. Gross profit margin, return on capital employed, return on equity, operating margin, and net margin are all low. Return on assets is slightly better but still below average. This suggests challenges in generating profits from its operations and assets. The healthcare industry's competitive pressures and regulatory environment may contribute to these challenges.

Efficiency Ratio Summary

Efficiency Score : 4.67

The company's efficiency ratios present a mixed picture. While days sales in inventory and receivable days are well-managed, turnover ratios for fixed assets, inventory, receivables, and capital are low. This suggests potential inefficiencies in asset utilization and working capital management. The healthcare industry's specific operational demands may influence these ratios, but improvements in asset turnover could enhance overall efficiency.

Coverage Ratio Summary

Coverage Score : 2.00

The company's coverage ratios are weak, particularly concerning the interest coverage ratio. This indicates potential difficulties in meeting interest obligations, which could increase financial risk. The healthcare industry's capital-intensive nature requires careful management of debt and interest expenses to ensure financial stability.

Solvency Ratio Summary

Solvency Score : 10.00

The company's solvency position is strong, primarily due to a high equity ratio and low debt levels. This indicates a solid financial foundation and lower risk of financial distress. The company's reliance on equity rather than debt provides stability and resilience. However, it's important to monitor whether this capital structure supports optimal growth and profitability in the long term.

Liquidity Ratio Summary

Liquidity Score : 2.00

The company's liquidity position is weak, with all liquidity ratios indicating poor short-term financial health. This suggests potential difficulties in meeting immediate obligations and managing working capital. The lack of liquid assets may hinder operational flexibility and increase financial risk. While the healthcare industry can have unique working capital cycles, these ratios raise concerns about the company's ability to handle unforeseen expenses or invest in growth opportunities.